Literature DB >> 3567049

Effects of time of dosing and age on intravenous aminophylline pharmacokinetics.

A Rodgers, K W Woodhouse, D N Bateman.   

Abstract

The elimination kinetics of theophylline were investigated following intravenous administration of aminophylline in 12 subjects (six fit young, and six healthy hospitalised elderly volunteers) at 09.00 h and 21.00 h on separate occasions at least 5 days apart to determine whether time of administration had significant effects on clearance in young and elderly subjects. We were unable to demonstrate a significant change in kinetic parameters between morning and evening administration in either young or elderly subjects. Our results also demonstrated no difference in kinetics between young and elderly subjects. We conclude that neither time of dosing nor age are important determinants of theophylline elimination kinetics in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3567049      PMCID: PMC1386234          DOI: 10.1111/j.1365-2125.1987.tb03055.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

Review 1.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

2.  Micro-scale method for theophylline in body fluids by reversed-phase, high-pressure liquid chromatography.

Authors:  J J Orcutt; P P Kozak; S A Gillman; L H Cummins
Journal:  Clin Chem       Date:  1977-03       Impact factor: 8.327

3.  Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.

Authors:  W J Jusko; M J Gardner; A Mangione; J J Schentag; J R Koup; J W Vance
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

4.  Pharmacokinetics of theophylline in night-workers.

Authors:  S Decourt; F Fodor; B Flouvat; A Pradalier; J Dry
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

5.  The pharmacokinetics of single doses of metoclopramide in renal failure.

Authors:  D N Bateman; R Gokal; T R Dodd; P G Blain
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Temporal variations in trough serum theophylline concentrations at steady state.

Authors:  L J Lesko; D Brousseau; A T Canada; G Eastwood
Journal:  J Pharm Sci       Date:  1980-03       Impact factor: 3.534

7.  Theophylline pharmacokinetics in advanced age.

Authors:  E J Antal; P A Kramer; S A Mercik; D J Chapron; I R Lawson
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

8.  Aging, cigarette smoking and oral theophylline requirement.

Authors:  T Talseth; N P Boye; J Kongerud; J E Bredesen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Influence of age on theophylline clearance in patients with chronic obstructive pulmonary disease.

Authors:  L A Bauer; R A Blouin
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

10.  Theophylline kinetics in relation to age: the importance of smoking.

Authors:  B Cusack; J G Kelly; J Lavan; J Noel; K O'Malley
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

View more
  4 in total

Review 1.  Chronopharmacology and its application to the development of theophylline treatment schedules for asthma.

Authors:  K R Godfrey
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Lack of effect of flosequinan on the pharmacokinetics of theophylline.

Authors:  F Kamali; C Edwards; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

3.  Is diurnal variation in absorption of slow-release aminophylline an age-related phenomenon?

Authors:  A Rodgers; D N Bateman; K W Woodhouse
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  The relationship between theophylline clearance and age in adult life.

Authors:  S H Jackson; A Johnston; R Woollard; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.